USP General Chapter <800> Compliance Toolkit and Resources for Psychiatric Facilities

Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 09/06/2018 - 09/06/2021

Target Audience

Pharmacists who handle HD preparations and work at facilities that store, prepare, transport, or administer HDs (e.g., pharmacies, hospitals or healthcare institutions, patient treatment clinics, physicians’ practice facilities, veterinarians’ offices).

Session Summary

The U.S. Pharmacopeial Convention (USP) has issued USP General Chapter <800> Hazardous Drug Handling in Healthcare Settings describing practice and quality standards for handling hazardous drugs (HDs) to promote patient safety, worker safety, and environmental protection. Handling HDs includes, but is not limited to, the receipt, storage, compounding, dispensing, administration, and disposal of sterile and nonsterile products and preparations. A psychiatric facility is unique in that the compounding of IV admixtures and the handling of antineoplastic drugs is extremely limited. Learn how to address the standards of USP 800 in a practical and effective manner that meets the needs of a psychiatric facility and balances the patient, worker and environmental safety with the needs for patient treatment.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Identify the criteria used to determine that a drug is hazardous.
  2. Describe processes used to identify hazardous drugs used within your facility.
  3. Develop an assessment of risk template that complies with USP 800.
  4. Discuss factors that influence the risk of exposure to a hazardous drug.
  5. Explain means to prevent exposure to hazardous drugs.

Continuing Education Credit and Disclosures

Activity Dates: 09/06/2018 - 09/06/2021
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-18-050-H05-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hours of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-18-050-H05-P.